Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma
Clinical trial NCT03695744 · UNKNOWN
Trial details
- NCT number
- NCT03695744
- Sponsor
- Singapore General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-02
- Primary completion
- 2021-09-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.